Nabriva Therapeutics plc Prepaid Expense, Current
Nabriva Therapeutics plc had Prepaid Expense, Current of $3.26 million as of 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2023-10-19
- 2023-06-30: Prepaid Expense, Current $3.26M.
- 2023-03-31: Prepaid Expense, Current $2.24M.
- 2022-12-31: Prepaid Expense, Current $2.15M.
- 2022-09-30: Prepaid Expense, Current $3.07M.
| Period end | Prepaid Expense, Current |
|---|---|
| 2023-06-30 | $3.26M 10-Q · filed 2023-10-19 |
| 2023-03-31 | $2.24M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $2.15M 10-Q · filed 2023-10-19 |
| 2022-09-30 | $3.07M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $6.24M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $4.60M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $5.16M 10-K · filed 2023-04-17 |
| 2021-09-30 | $5.61M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $11.60M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $10.22M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $5.88M 10-K · filed 2022-03-29 |
| 2020-09-30 | $3.75M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.92M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.92M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.16M 10-K · filed 2021-03-11 |
| 2019-09-30 | $1.20M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.40M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $973.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $1.15M 10-K · filed 2020-03-12 |
| 2018-09-30 | $1.16M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.15M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.02M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $1.56M 10-K · filed 2019-03-12 |
| 2017-09-30 | $1.51M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.35M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $903.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.18M 10-K · filed 2018-03-16 |
| 2015-12-31 | $610.00K 10-K · filed 2017-03-24 |